Skip to content

13F-HR filed by HealthCor Management, L.P.

HealthCor Management, L.P. filed this 13F-HR for the quarter ended 2013-09-30, filed 2013-11-14, with 58 holding rows worth $1,865,689,000.

Accession
0001343781-13-000007
Filed
2013-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2013

A holdings report, 58 entries on the cover page, a total value of $1,865,689,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,865,689,000 with VALUE read as thousands by filing date, 13F file number 028-11790. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
VERADIGM INC01988P108COMMON STOCK11,000,000$163,570,000thousands by filing date
Gilead Sciences,Inc.375558103COM1,500,000$94,305,000thousands by filing date
ARTHROCARE CORP043136100COM2,300,000$81,834,000thousands by filing date
Intuitive Surgical,Inc.46120E602COM214,554$80,730,000thousands by filing date
Gilead Sciences,Inc.375558103COM1,251,500$78,682,000thousands by filing dateput
WRIGHT MED GROUP INC98235T107COM3,000,000$78,240,000thousands by filing date
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock925,000$75,980,000thousands by filing date
EHEALTH INC28238P109COM2,252,119$72,653,000thousands by filing date
CUBIST PHARMACEUTICALS INC229678107COM925,000$58,784,000thousands by filing date
CUBIST PHARMACEUTICALS INC229678107COM900,000$57,195,000thousands by filing dateput
ACTAVIS INC00507K103COM375,000$54,000,000thousands by filing date
ALLERGAN INC018490102COM545,000$49,295,000thousands by filing date
AbbVie,Inc.00287Y109COM1,050,000$46,967,000thousands by filing date
BEAM INC073730103COMMON STOCK725,000$46,871,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM400,000$46,464,000thousands by filing date
MYLAN INC628530107COM1,200,000$45,804,000thousands by filing date
WHITEWAVE FOODS COMPANY966244105COMMON STOCK2,275,000$45,432,000thousands by filing date
AETNA INC NEW00817Y108COM700,000$44,814,000thousands by filing date
MOLINA HEALTHCARE INC60855R100COM1,100,000$39,160,000thousands by filing date
AGILENT TECHNOLOGIES INC COM00846U101Stock750,000$38,438,000thousands by filing date
AEGERION PHARMACEUTICALS INC00767E102COM425,000$36,444,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock850,000$35,012,000thousands by filing date
EDWARDS LIFESCIENCES CORP COM28176E108Stock500,000$34,815,000thousands by filing date
MONSANTO CO NEW61166W101COM325,000$33,920,000thousands by filing date
THERAVANCE INC88338T104COMMON STOCK700,000$28,609,000thousands by filing date
ALKERMES PLCG01767105SHS825,000$27,737,000thousands by filing date
PHARMACYCLICS INC716933106COM200,000$27,652,000thousands by filing dateput
IMPAX LABORATORIES INC45256B101COM1,112,400$22,771,000thousands by filing date
MCKESSON CORP COM58155Q103Stock173,218$22,224,000thousands by filing date
ZOETIS INC CL A98978V103Stock675,000$21,006,000thousands by filing date
LAUDER ESTEE COS INC CL A518439104Stock300,000$20,970,000thousands by filing date
DYNAVAX TECHNOLOGIES CORP268158102COM17,600,000$20,944,000thousands by filing date
ACORDA THERAPEUTICS INC00484M106COM550,000$18,810,000thousands by filing date
Cynosure, Inc.232577205COM725,000$16,537,000thousands by filing date
SALIX PHARMACEUTICALS INC795435106COM245,300$16,406,000thousands by filing datecall
PTC THERAPEUTICS INC69366J200COM732,200$15,713,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM256,021$15,566,000thousands by filing date
WELLPOINT INC94973V107COM175,000$14,632,000thousands by filing date
WEBMD HEALTH CORP94770V102COM450,000$12,848,000thousands by filing date
NOVAVAX INC670002104COMMON STOCK3,498,000$11,019,000thousands by filing date
CELLDEX THERAPEUTICS INC NEW15117B103COM300,000$10,629,000thousands by filing datecall
NUVASIVE INC670704105COM425,000$10,408,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM200,000$9,446,000thousands by filing dateput
REGULUS THERAPEUTICS INC75915K101COM975,000$9,194,000thousands by filing date
CORVEL CORP COM221006109Stock218,000$8,059,000thousands by filing date
COCA COLA ENTERPRISES INC NE19122T109COM200,000$8,042,000thousands by filing date
EXELIXIS INC COM30161Q104Stock1,255,350$7,306,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM150,000$7,084,000thousands by filing datecall
Pfizer Inc.717081103COM235,500$6,765,000thousands by filing date
CHIMERIX INC COM16934W106Stock300,000$6,594,000thousands by filing date
Eli Lilly and Company532457108COM121,929$6,137,000thousands by filing date
IDERA PHARMACEUTICALS INC45168K306COM3,270,000$5,690,000thousands by filing date
INTERMUNE INC45884X103COM271,100$4,170,000thousands by filing date
Thermo Fisher Scientific Inc.883556102COM40,926$3,771,000thousands by filing date
METTLER TOLEDO INTERNATIONAL COM592688105Stock12,514$3,004,000thousands by filing date
THE COOPER COMPANIES216648402COM NEW21,969$2,849,000thousands by filing date
HCP INC40414L109COM67,300$2,756,000thousands by filing date
CELLDEX THERAPEUTICS INC NEW15117B103COM26,300$932,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001343781-13-000007this filing2013-11-14acceptance time not in the bulk data set